Brain stimulation for PTSD in first responders
Treatments studied
Part of Mental health clinical trials.
This trial tests a type of brain stimulation called repetitive transcranial magnetic stimulation (rTMS) combined with a medication called D-cycloserine to help first responders with post-traumatic stress disorder (PTSD). It aims to reduce PTSD symptoms by targeting brain areas involved in fear and memory.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a first responder (active, on leave, or retired) aged 19 to 60.
- You have a PTSD diagnosis, with a specific score of at least 25 on a standard PTSD scale.
- You are not currently taking any new psychiatric medications, and your depression score is not too high.
- You are not pregnant, do not have active suicidal thoughts, and do not have severe substance use (except tobacco) in the last 3 months.
- You have not received rTMS before, and you do not have certain medical implants or metal in your head that are unsafe for MRI or TMS.
- You do not have certain psychiatric conditions (like schizophrenia, primary OCD, or severe personality disorder) or significant neurological issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a non-invasive brain treatment called TMS, which uses magnetic pulses to stimulate brain areas involved in PTSD, along with a medication called D-cycloserine that may help the treatment work better. It is designed for current or former military members with PTSD.
This trial tests whether a type of brain stimulation called iTBS (which uses magnetic pulses) added to a standard PTSD therapy (EMDR) helps reduce PTSD symptoms more than EMDR alone. It involves 16 weeks of treatment and requires some commitments like avoiding alcohol.
This study tests whether a non-invasive brain stimulation technique called TMS can help reduce intrusive memories in people with PTSD. It uses MRI to guide the stimulation, and you will be randomly assigned to receive either active TMS or a placebo-like treatment.
This study tests transcranial magnetic stimulation (TMS) as a treatment for PTSD in Veterans. TMS uses magnetic pulses to stimulate brain areas linked to PTSD, aiming to reduce symptoms without medication.
This trial tests an accelerated form of transcranial magnetic stimulation (TMS) given daily for five days to treat PTSD. It may be an option for adults with moderate to severe PTSD who cannot get enough relief from standard treatments.
This study tests if personalized brain stimulation guided by your brain waves (EEG) can reduce PTSD symptoms. It's for veterans and first responders who have had PTSD for at least 6 months.
Hear when a new PTSD - Post Traumatic Stress Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.